-
Trehalose-Loaded LNPs Improve mRNA Stability
2026-08-25
The reference study introduces a dual-function trehalose strategy in which the sugar protects both the LNP exterior and the encapsulated mRNA during lyophilization. Its key contribution is showing that chemical protection and reduced oxidative stress can improve the relationship between in vitro formulation metrics and in vivo expression.
-
Protease Inhibitor Cocktail for p53 Assays
2026-08-24
The Protease Inhibitor Cocktail supports protein degradation prevention in p53, Western blot, and interaction assays. This article connects EDTA-free sample preservation with the mechanistic interpretation of the MLF2–p53–USP7 axis, offering an assay-selection framework beyond routine extraction guidance.
-
IRG1–Itaconic Acid Control of TBK1 Signaling
2026-08-24
A 2025 Cell Reports study identifies the IRG1–itaconic acid axis as a metabolic feedback mechanism that restrains excessive TBK1-dependent type I interferon signaling. By showing that itaconic acid alkylates TBK1 at Cys605 and disrupts dimerization, the authors provide a mechanistic basis for itaconic acid-derived inhibitors ITA-5 and ITA-9 as candidates for controlling IFN-I-driven hyperinflammation.
-
SlSLAH1 and Malate Exudation in Tomato Aluminium Tolerance
2026-08-23
This study identifies SlSLAH1 as a plasma membrane malate transporter that is central to aluminium tolerance in tomato. It further defines a two-layer mechanism in which the SlSTOP1–SlSZP1 transcriptional complex activates SlSLAH1, while SlSLAH2 associates with SlSLAH1 to strengthen malate exudation from roots.
-
Protease Inhibitor Cocktail for Signaling Assays
2026-08-22
Discover how a Protease Inhibitor Cocktail preserves signaling-relevant proteins without EDTA, with practical guidance for hypoxia, EGFR-resistance, Western blot, and kinase workflows. This article connects extraction chemistry to assay interpretation rather than treating inhibition as a routine add-on.
-
Dehydroabietic Acid: Dual PPAR-α/γ Agonist
2026-08-22
Dehydroabietic acid is a resin-derived small molecule described as a dual PPAR-α/γ agonist for research on lipid metabolism regulation and insulin sensitivity. Its organic-solvent solubility, storage requirements, and research-use-only status should guide assay design and interpretation.
-
AEBSF.HCl in Lysosomal Necroptosis Assays
2026-08-21
AEBSF.HCl is more than a broad-spectrum serine protease inhibitor: it can function as a pathway-dissection tool in lysosomal membrane permeabilization and necroptosis research. This article connects its chemistry to MLKL-driven cathepsin release while defining what the reagent can—and cannot—prove in cell-death assays.
-
Pazopanib in ATRX-Deficient Glioma Research
2026-08-20
Pazopanib (GW-786034) provides a practical way to test multi-pathway RTK blockade in genetically defined glioma models. This workflow connects ATRX status, VEGF signaling pathway readouts, dose-response analysis, and temozolomide combination studies while emphasizing formulation control and assay-specific interpretation.
-
Protease Inhibitor Cocktail for Plant Extracts
2026-08-20
Protect plant proteins from harvest through Western blotting, co-immunoprecipitation, pull-down, and kinase assays with broad-spectrum, EDTA-free inhibition. This workflow shows how the reagent can preserve abundance-sensitive STOP1 and STAR1 measurements while helping researchers troubleshoot proteolysis, phosphatase activity, and DMSO-related assay effects.
-
Lipo3K Transfection Reagent for Resistance Studies
2026-08-19
Use Lipo3K Transfection Reagent to build reproducible DNA, siRNA, and co-transfection workflows for transporter biology and paclitaxel-resistance research. Its low-toxicity profile, plasmid enhancer, and compatibility with adherent or suspension cells help connect delivery quality with mechanistic assay confidence.
-
Melatonin Blocks RIPK3 Necroptosis in Atrazine Kidney Injury
2026-08-19
The reference study identifies RIPK3-dependent necroptosis as a central mechanism of atrazine-induced renal tubular injury and shows that melatonin suppresses this response in cellular and animal models. Its combination of pathway interrogation, RIPK3 knockdown, and molecular docking provides a mechanistic framework for studying chemically induced nephrotoxicity beyond nonspecific oxidative stress.
-
EZ Cap™ Cas9 mRNA (m1Ψ): Precision by Design
2026-08-18
EZ Cap™ Cas9 mRNA (m1Ψ) combines a Cap1 structure, m1Ψ modification, and poly(A) tail for controlled CRISPR-Cas9 genome editing in mammalian cells. This article goes beyond routine optimization by showing how Cas9 mRNA processing and nuclear export can become practical variables for interpreting editing specificity.
-
Protease Inhibitor Cocktail EDTA-Free Guide
2026-08-18
The Protease Inhibitor Cocktail EDTA-Free is a 100X DMSO formulation for broad protease suppression during protein extraction and lysate preparation. Its EDTA-free design supports phosphorylation analysis and other assays that require divalent cations, but it should not be treated as a phosphatase inhibitor or universal protease blocker.
-
Chloroquine Diphosphate for Autophagy Assays
2026-08-17
Build more informative autophagy, combination-treatment, and resistance-model experiments with Chloroquine Diphosphate. This workflow emphasizes aqueous formulation, concentration-response design, lysosomal interpretation, and orthogonal controls for chemotherapy sensitization and radiotherapy sensitization studies.
-
Protease Inhibitor Cocktail: EDTA-Free Workflow
2026-08-17
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolysis during protein extraction, cell-based workflows, and downstream assays that require preservation of divalent cations. It is appropriate for applications such as Western blotting, co-immunoprecipitation, kinase assays, and phosphorylation analysis, but it should not be treated as an EDTA substitute when metal chelation is required.